Tag Archives: disease

Year in Review: Crohn's Disease

Treatment of Crohn’s disease has continued to improve during 2018, with broader use of ustekinumab (Stelara) and vedolizumab (Entyvio), and promising results being seen for bezlotoxumab (Zinplava) for recurrent Clostridium difficile infections. However, while mortality has declined with anti-tumor necrosis factor (TNF) treatment overall, children diagnosed with inflammatory bowel disease (IBD) had triple the mortality… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »